Fund Houses Recommendations: VBL, HDFCLIFE, HDFCAMC, VODAFONE, TORRENTPHARMA, NEULANDLABS

અમદાવાદ, 16 જુલાઇઃ અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ દ્વારા પસંદગીના સ્ટોક્સમાં ખરીદી/ વેચાણ/ હોલ્ડ કરવા માટે સલાહ આપવામાં આવી છે તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

MS on VBL: Maintain Overweight on Company, raise target price at Rs 1701 (Positive)

JP Morgan on Bharti Hexacom: Initiate Overweight on Company, target price at Rs 1280 (Positive)

GS on HDFC Life: Maintain Buy on Company, raise target price at Rs 765 (Positive)

Jefferies on HDFC Life: Maintain Buy on Company, target price at Rs 750 (Positive)

HSBC on HDFC Life: Maintain Buy on Company, raise target price at Rs 760 (Positive)

Citi on HDFC Life: Maintain Buy on Company, raise target price at Rs 735 (Positive)

MS on HDFC Life: Maintain Overweight on Company, raise target price at Rs 790 (Positive)

Jefferies on HDFC AMC: Maintain Buy on Company, raise target price at Rs 4900 (Positive)

Citi on Vodafone Idea: Maintain Buy on Company, target price at Rs 23 (Positive)

GS on Torrent Pharma: Maintain Buy on Company, raise target price at Rs 3125 (Positive)

GS on Neuland Labs: Maintain Buy on Company, raise target price at Rs 10200 (Positive)

JP Morgan on Gas stocks: Data from the PPAC and CEA suggests LNG imports increased meaningfully in April / May due to higher demand from power plants. Prefer Petronet, MGL and IGL (Positive)

MS on Apollo Tyre: Maintain Equal weight on Company, target price at Rs 472 (Neutral)

MS on HDFC AMC: Maintain Equal weight on Company, target price at Rs 3640 (Neutral)

HSBC on HDFC AMC: Maintain Hold on Company, target price at Rs 4030 (Neutral)

CLSA on HDFC Life: Maintain Outperform on Company, target price at Rs 700 (Neutral)

Macquarie on HDFC Life: Maintain Neutral on Company, target price at Rs 560 (Neutral)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)